# Sprout Pharmaceuticals, Inc.: Form D filings

Sprout Pharmaceuticals, Inc., a pharmaceuticals company in Raleigh, NC, filed 7 Form D notices with the SEC between 2012 and 2015. The latest, on June 8, 2015, reports $50 million sold of a $50 million offering to 5 investors.

Find out what Sprout Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Sprout%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Sprout%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsprout-pharmaceuticals-inc-1545211)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Sprout%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Sprout%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsprout-pharmaceuticals-inc-1545211)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4208 SIX FORKS ROAD, SUITE 1010, Raleigh, NC, 27609
- Phone: (919) 882-0850
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2011
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1545211

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 8, 2015 | New notice | $50,000,008 | $50,000,008 | $0 | 5 | May 22, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1545211/000154521115000001/0001545211-15-000001-index.htm) |
| Jul 11, 2014 | New notice | $15,000,000 | $4,303,856 | $10,696,144 | 69 | Jun 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1545211/000154521114000001/0001545211-14-000001-index.htm) |
| Jul 26, 2013 | Amendment | $10,000,000 | $9,999,997 | $3 | 88 | Jun 11, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1545211/000154521113000002/0001545211-13-000002-index.htm) |
| Jun 25, 2013 | New notice | $10,000,000 | $4,791,913 | $5,208,087 | 63 | Jun 11, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1545211/000154521113000001/0001545211-13-000001-index.htm) |
| Jul 11, 2012 | Amendment | $20,000,000 | $20,000,000 | $0 | 59 | Jun 15, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1545211/000154521112000004/0001545211-12-000004-index.htm) |
| Jun 29, 2012 | New notice | $20,000,000 | $17,554,341 | $2,445,659 | 55 | Jun 15, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1545211/000154521112000003/0001545211-12-000003-index.htm) |
| Mar 21, 2012 | New notice | $5,000,000 | $5,000,000 | $0 | 61 | Mar 8, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1545211/000154521112000002/0001545211-12-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Anne S. Tomalin | Executive Officer |  |
| Anthony S. Wild | Director |  |
| Matthew S. Petzold | Executive Officer |  |
| Douglas S. Eckert | Executive Officer, Director |  |
| Robert S. Whitehead | Executive Officer, Director |  |
| Josephine S. Torrente | Executive Officer |  |
| James S. Pruden | Executive Officer |  |
| Rich S. Franco | Executive Officer |  |
| Braxton Robert Goodrich | Director |  |
| Richard Robert DeSchutter | Director |  |
| W. Robert Dahl | Director |  |
| Trygve Robert Mikkelsen | Director |  |
| Michael Robert Ford | Director |  |
| Cynthia Whitehead | Executive Officer, Director |  |

## Other pharmaceuticals companies in North Carolina that filed recently

- [Dignify Therapeutics, LLC](https://specstream.ai/data/form-d/company/dignify-therapeutics-llc-1622906) $800,000 · Sep 25, 2026

[Every Form D from the week of Jun 8, 2015](https://specstream.ai/data/form-d/week/2015-06-08) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Sprout Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).